These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 19097660)

  • 1. Urethral stricture following high dose rate brachytherapy for prostate cancer.
    Sullivan L; Williams SG; Tai KH; Foroudi F; Cleeve L; Duchesne GM
    Radiother Oncol; 2009 May; 91(2):232-6. PubMed ID: 19097660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for the development of prostate brachytherapy related urethral strictures.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Allen ZA; Adamovich E
    J Urol; 2006 Apr; 175(4):1376-80; discussion 1381. PubMed ID: 16516001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer.
    Khor R; Duchesne G; Tai KH; Foroudi F; Chander S; Van Dyk S; Garth M; Williams S
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):679-85. PubMed ID: 22954770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dosimetry of prostate brachytherapy-induced urethral strictures.
    Merrick GS; Butler WM; Tollenaar BG; Galbreath RW; Lief JH
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):461-8. PubMed ID: 11872293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
    Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results.
    Duchesne GM; Williams SG; Das R; Tai KH
    Radiother Oncol; 2007 Aug; 84(2):128-34. PubMed ID: 17561293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer.
    Pellizzon AC; Salvajoli JV; Maia MA; Ferrigno R; Novaes PE; Fogarolli RC; Pellizzon RJ
    J Urol; 2004 Mar; 171(3):1105-8. PubMed ID: 14767280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting for urinary incontinence after prostate brachytherapy.
    McElveen TL; Waterman FM; Kim H; Dicker AP
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1395-404. PubMed ID: 15275725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomy-based inverse planning dose optimization in HDR prostate implant: a toxicity study.
    Mahmoudieh A; Tremblay C; Beaulieu L; Lachance B; Harel F; Lessard E; Pouliot J; Vigneault E
    Radiother Oncol; 2005 Jun; 75(3):318-24. PubMed ID: 16086913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
    Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
    Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose-rate brachytherapy for large prostate volumes (> or =50cc)-Uncompromised dosimetric coverage and acceptable toxicity.
    Monroe AT; Faricy PO; Jennings SB; Biggers RD; Gibbs GL; Peddada AV
    Brachytherapy; 2008; 7(1):7-11. PubMed ID: 18299109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy.
    Ghadjar P; Keller T; Rentsch CA; Isaak B; Behrensmeier F; Stroux A; Thalmann GN; Aebersold DM
    Brachytherapy; 2009; 8(1):45-51. PubMed ID: 19038584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective dose escalation trial of high-dose-rate brachytherapy boost for prostate cancer: Evidence of hypofractionation efficacy?
    Tang JI; Williams SG; Tai KH; Dean J; Duchesne GM
    Brachytherapy; 2006; 5(4):256-61. PubMed ID: 17118320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
    Pinkawa M; Fischedick K; Treusacher P; Asadpour B; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ
    Radiother Oncol; 2006 Jan; 78(1):41-6. PubMed ID: 16271785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose-rate brachytherapy plus external beam radiotherapy for T1 to T3 prostate cancer: an experience in Taiwan.
    Chen YC; Chuang CK; Hsieh ML; Chen WC; Fan KH; Yeh CY; Lee CC; Hong JH
    Urology; 2007 Jul; 70(1):101-5. PubMed ID: 17656217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute adverse effects of high dose brachytherapy in combination with external radiotherapy in localized prostate cancer].
    Soumarová R; Homola L; Stursa M; Perková H
    Cas Lek Cesk; 2006; 145(1):43-9. PubMed ID: 16468241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of recurrence of urethral stricture disease following optical urethrotomy.
    Zehri AA; Ather MH; Afshan Q
    Int J Surg; 2009 Aug; 7(4):361-4. PubMed ID: 19500695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.